medigraphic.com
SPANISH

Revista Mexicana de Oftalmología

Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2010, Number 2

<< Back Next >>

Rev Mex Oftalmol 2010; 84 (2)

Endoftalmitis endógena por Fusarium spp en un paciente con onicomicosis: reporte de un caso

Tamez-Peña A, González-González LA, López-Jaime GR, Rodríguez-García A
Full text How to cite this article

Language: Spanish
References: 10
Page: 122-126
PDF size: 173.83 Kb.


Key words:

endogenous endophthalmitis, Fusarium spp, onychomycosis.

ABSTRACT

Endogenous or metastatic endophthalmitis is a rare intraocular infection whose incidence has upraised in the last decades. We describe herein a 59 years old diabetic man who developed a fungal endogenous endophthalmitis secondary to a complicated onycho-mycosis of the first right toe. The patient had a past ocular history of misdiagnosis of non-infectious panuveitis and a failed treatment with high-dose systemic, periocular and topical corticosteroids. The patient decided to take a second opinion because of worsening of red eye, progressive visual loss, moderate ocular pain, tearing and photophobia in the left eye after a four-day period post-transeptal injection of 40 mg depot methyl-prednisolone.
Upon arrival to our Service, an urgent vitreous and aqueous tap, as well as a nail biopsy of the first right toe were performed. Smear and culture results from the vitreous and nail toe came back positive for Fusarium spp., confirming the diagnosis of fungal endogenous endophthalmitis. The patient was aggressively treated with two intravitreal amphotericin- B (0.5 mg/0.1 ml) injections, topical 5% nathamycin, and systemic fluconazole (300 mg q.d. PO) for several weeks despite of which, and due to the advanced state of infection and previous erroneous massive steroid therapy, the visual outcome was unfavorable.
To the best of our knowledge, this is the first case report of metastatic Fusarium endophthalmitis secondary to a complicated toe onychomycosis.


REFERENCES

  1. Najmi NG, Song HF, Ober RR. Presumed Candida endogenous fungal endophthalmitis: a case report and literature review. Optometry 2007; 78(9):454-459.

  2. Thomas PA. Current Perspectives on Ophthalmic Mycoses Clin Microbiol Rev 2003; 16(4):730-797.

  3. Sá MB, Zaragoza R. Critical overview of clinical guidelines relating to invasive fungal infections. Int J Antimicrob Agents 2008, 32(Supl 2):S155-159.

  4. Klotz SA, Penn CC, Negvesky GJ, Butrus SU. Fungal and parasitic infections of the eye. Clin Microbiol Rev 2000; 13:662-685.

  5. Stanzani M, TumiettoF, Vianelli N, Baccaran M. Update on the treatment of disseminated fusariosis: Focus on voriconazole. Clin Risk Manag 2007; 3(6):1165-1173.

  6. Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol 2005;139(1):135-140.

  7. Ferrer C, Alio J, Rodriguez A, Andreu M, Colom F. Endophthalmitis caused by Fusarium proliferatum. J Clin Microbiol 2005; 43:5372-5375.

  8. Dursun D, Fernandez V, Miller D, Alfonso EC. Advanced fusarium keratitis progressing to endophthalmitis. Cornea 2003;22(4):300-303.

  9. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004;10 (Supl 1):67-75.

  10. Tasman W, Jaeger EA. Duane’s clinical ophthalmology. Philadelphia, Lippincott, Williams & Wilkins, 2005.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Oftalmol. 2010;84